As of December 2024 Revance Therapeutics has a market cap of $0.32 Billion USD. This makes Revance Therapeutics the world's 7474th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 25th, 2024 the market cap of Revance Therapeutics was reported to be: